Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

Swedish Orphan Biovitrum AB (publ) (Sobi), an international specialty health-care company, aims to be recognized as a global leader in providing access to innovative treatments that transform the ...

Sobi’s sNDA is supported by data from the AVA ... Avatrombopag, known under the brand name DOPTELET, is a thrombopoietin receptor agonist (TPO-RA) that does not compete with thrombopoietin ...